Dermatologic Adverse Effects of Anticancer Therapy III: Targeted and Immunotherapies

Targeted and immunotherapies comprise two of the most promising and expanding classes of agents in oncology. This chapter reviews clinical indications for targeted and immunotherapies, and describes their corresponding associated dermatologic adverse effects (DAEs) in these settings. For each medication discussed, a clinical synopsis is provided which showcases incidence, natural course, clinical features, and management of potential mucocutaneous reactions. This chapter is designed to assist clinicians in anticipating, recognizing, and managing the dermatologic manifestations of these increasingly utilitzed therapies.